Aims of the meeting:
- Share lived experience and evidence of drug quality issues
- Discuss pharmacological, clinical and operational implications
- Propose actionable solutions to support partner centres
- Develop a practical roadmap for future work
Proposed Schedule (details TBC) with presentations from:
- Prof Girish Chinnaswamy, Tata Memorial Hospital, Mumbai, India
- Experience from India and the National Cancer Grid. Testing of chemotherapeutic agents, biologics, PK studies, and procurement processes. Challenges in identifying reliable manufacturers. Importance of random testing and pharmacovigilance.
- Dr Barry Goldspiel, Oncology pharmacist and president-elect International Society of Oncology Pharmacy Practitioners (ISOPP)
- Work of the International Society of Oncology Pharmacy Practitioners. Existing ISOPP taskforce activity related to medication quality assurance. Practical pharmacy considerations (handling, storage, appearance checks, etc.).
- Representative from St Jude Global, St Jude Childrens’ Research Hospital, Memphis, USA
- Expert-led discussion and Q+A
